- Conditions
- Food Allergy, Anaphylaxis, Food Hypersensitivity, Food Allergy Peanut
- Interventions
- Epinephrine Auto-Injector 0.3 mg/0.3 mL, Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle, IN-001 9.06 mg Sublingual Spray, IN-001 13.59 mg Sublingual Spray
- Drug
- Lead sponsor
- Insignis Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 107
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Peanut Allergy
- Interventions
- DBV712 250 mcg
- Biological
- Lead sponsor
- DBV Technologies
- Industry
- Eligibility
- 2 Years to 5 Years
- Enrollment
- 304 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2025
- U.S. locations
- 26
- States / cities
- Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 22 more
- Conditions
- Peanut Allergy
- Interventions
- Dose A, Dose B, Dose C, Dose D, Dose E, Placebo
- Combination Product
- Lead sponsor
- Moonlight Therapeutics, Inc.
- Industry
- Eligibility
- 4 Years to 55 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 5
- States / cities
- Little Rock, Arkansas • Atlanta, Georgia • Overland Park, Kansas + 2 more
- Conditions
- Peanut Hypersensitivity, Food Hypersensitivity, Immediate Hypersensitivity
- Interventions
- Peanut powder, Peanut extract, Placebo extract, Placebo powder
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 6 Years to 21 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Peanut Hypersensitivity
- Interventions
- Peanut protein
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 1 Year to 16 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2014
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Peanut Allergy, Milk Allergy, Egg Allergy
- Interventions
- Oral food challenge
- Procedure
- Lead sponsor
- National Jewish Health
- Other
- Eligibility
- 3 Years to 21 Years
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Food Allergy, Peanut Allergy
- Interventions
- Peanut Protein, Continued peanut avoidance
- Biological · Other
- Lead sponsor
- Scott Sicherer
- Other
- Eligibility
- 4 Years to 14 Years
- Enrollment
- 73 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Peanut Allergy
- Interventions
- AR101
- Biological
- Lead sponsor
- Aimmune Therapeutics, Inc.
- Industry
- Eligibility
- 4 Years to 17 Years
- Enrollment
- 243 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 55
- States / cities
- Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 45 more
- Conditions
- Peanut Allergy
- Interventions
- Omalizumab
- Drug
- Lead sponsor
- Lynda Schneider
- Other
- Eligibility
- 7 Years to 25 Years
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Food Allergy
- Interventions
- Glucopyranosyl Lipid A (GLA), Sublingual Immuno Therapy (SLIT) Peanut Extract (PE), Placebo for GLA, Placebo for SLIT PE
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 12 Years to 55 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 16
- States / cities
- Little Rock, Arkansas • Mission Viejo, California • San Diego, California + 12 more
- Conditions
- Cashew Nut Allergy, Tree Nut Allergies
- Interventions
- Cashew sublingual immunotherapy, Placebo sublingual immunotherapy
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 1 Year to 11 Years
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Immune System Diseases
- Interventions
- PVX-108, Placebo
- Biological
- Lead sponsor
- Aravax Pty Ltd
- Industry
- Eligibility
- 4 Years to 17 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 8
- States / cities
- Little Rock, Arkansas • Rolling Hills Estates, California • Atlanta, Georgia + 5 more
- Conditions
- Peanut Allergy
- Interventions
- Dupilumab
- Drug
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 6
- States / cities
- Mountain View, California • Tampa, Florida • Indianapolis, Indiana + 3 more
- Conditions
- Peanut Allergy
- Interventions
- Part A Viaskin Peanut 250 mcg, Part A Viaskin Peanut 100 mcg, Part A Placebo, Part B Viaskin Peanut 250 mcg, Part B Placebo
- Biological
- Lead sponsor
- DBV Technologies
- Industry
- Eligibility
- 1 Year to 3 Years
- Enrollment
- 414 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 27
- States / cities
- Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 23 more
- Conditions
- Food Allergy
- Interventions
- Trichuris suis ova (TSO)
- Drug
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Peanut Allergy
- Interventions
- ASP0892 Intradermal, ASP0892 Intramuscular, Placebo Intradermal, Placebo Intramuscular
- Drug
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 8
- States / cities
- Little Rock, Arkansas • Mountain View, California • Baltimore, Maryland + 5 more
- Conditions
- Peanut Allergy
- Interventions
- CNP-201, Placebo
- Drug
- Lead sponsor
- COUR Pharmaceutical Development Company, Inc.
- Industry
- Eligibility
- 16 Years to 55 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Long Beach, California • Mission Viejo, California + 13 more
- Conditions
- Peanut Allergy
- Interventions
- Not listed
- Lead sponsor
- Weill Medical College of Cornell University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Allergy and Immunology, Peanut and Nut Allergy, Egg Allergy, Food Allergy in Infants, Food Allergy Peanut
- Interventions
- Consumption, Avoidance
- Behavioral
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 1 Day and older · Female only
- Enrollment
- 500 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Peanut Allergy
- Interventions
- Peanut Dissolving Film
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 2
- States / cities
- Baltimore, Maryland • New York, New York
- Conditions
- Allergy, Peanut
- Interventions
- DBV712, Placebo
- Drug · Other
- Lead sponsor
- DBV Technologies
- Industry
- Eligibility
- 4 Years to 7 Years
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2029
- U.S. locations
- 50
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 42 more
- Conditions
- Peanut Allergic Subjects
- Interventions
- Peanut Oral Immunotherapy (POIT)
- Biological
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 5 Years to 16 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2020
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Peanut Allergy
- Interventions
- Epicutaneous skin prick testing
- Other
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2015
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Peanut Allergy
- Interventions
- ASP0892, Placebo
- Drug
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 7
- States / cities
- Little Rock, Arkansas • Mountain View, California • Chicago, Illinois + 4 more